These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2179525)

  • 41. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
    N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
    [No Abstract]   [Full Text] [Related]  

  • 42. Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients.
    Silvestris F; Camarda G; Del Prete A; Tucci M; Dammacco F
    Eur J Clin Invest; 1999 Nov; 29(11):980-91. PubMed ID: 10583444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies.
    Ovod V; Lagerstedt A; Ranki A; Gombert FO; Spohn R; Tähtinen M; Jung G; Krohn KJ
    AIDS; 1992 Jan; 6(1):25-34. PubMed ID: 1371924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The HIV-1 Nef protein shares an antigenic determinant with a T-cell surface protein.
    Scheider T; Beck A; Röpke C; Ullrich R; Harthus HP; Bröker M; Pauli G
    AIDS; 1993 May; 7(5):647-54. PubMed ID: 7686375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
    Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
    Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is anti-p27nef a useful diagnostic and prognostic marker in HIV-1 infection?
    Marty L; Laperche S; Bouchardeau F; Faucher V; Lefrere JJ; Couroucé AM
    AIDS; 1990 Nov; 4(11):1170-1. PubMed ID: 2282200
    [No Abstract]   [Full Text] [Related]  

  • 51. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein.
    Moynier M; Kavsan V; Gales C; Montagnier L; Bahraoui E
    Vaccine; 1998 Oct; 16(16):1523-30. PubMed ID: 9711799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs): rapid differentiation between HIV-1 and HIV-2 infection.
    Gilmour JE; Read SJ; Eglin R; Ryan C; Burns NR; Graff N; Stenner N; Kingsman SM; Kingsman AJ; Adams SE
    AIDS; 1990 Oct; 4(10):967-73. PubMed ID: 2124493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
    Siakkou H; Jahn S; Kienzle N; Ulrich R; Grötzinger C; Schneider T; Kohleisen B; Pauli G; Spohn R; Jung G
    Arch Virol; 1993; 128(1-2):81-95. PubMed ID: 7678193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells.
    Fujii Y; Otake K; Tashiro M; Adachi A
    FEBS Lett; 1996 Sep; 393(1):93-6. PubMed ID: 8804432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
    Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
    J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.
    Verity EE; Zotos D; Wilson K; Chatfield C; Lawson VA; Dwyer DE; Cunningham A; Learmont J; Dyer W; Sullivan J; Churchill M; Wesselingh SL; Gabuzda D; Gorry PR; McPhee DA
    J Virol; 2007 Sep; 81(17):9268-78. PubMed ID: 17567690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV excretion patterns and specific antibody responses in body fluids.
    O'Shea S; Cordery M; Barrett WY; Richman DD; Bradbeer C; Banatvala JE
    J Med Virol; 1990 Aug; 31(4):291-6. PubMed ID: 2125310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.